Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents
Femasys Inc., a biomedical innovator in non-surgical permanent birth control solutions, announced the issuance of new U.S. and international patents covering the blended polymer component of its FemBloc technology. These patents complement existing delivery system patents and broaden global intellectual property protection across key markets includ…